Showing 1 - 4 results of 4 for search 'P. H. Elsinga', query time: 0.02s Refine Results
  1. 1
    Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?

    Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals? by E. F. J. de Vries, P. H. Elsinga, C. Tsoumpas

    Published 2022-12-01
    Get full text
    Article
  2. 2
    New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals

    New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals by I. F. Antunes, G. M. Franssen, R. Zijlma, P. Laverman, H. H. Boersma, P. H. Elsinga

    Published 2020-05-01
    Get full text
    Article
  3. 3
    Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia

    Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia by X. Zhou, J. Doorduin, P.H. Elsinga, R.A.J.O. Dierckx, E.F.J. de Vries, C. Casteels

    Published 2017-08-01
    Get full text
    Article
  4. 4
    Improved GMP-compliant multi-dose production and quality control of 6-[18F]fluoro-L-DOPA

    Improved GMP-compliant multi-dose production and quality control of 6-[18F]fluoro-L-DOPA by G. Luurtsema, H. H. Boersma, M. Schepers, A. M. T. de Vries, B. Maas, R. Zijlma, E. F. J. de Vries, P. H. Elsinga

    Published 2016-04-01
    Get full text
    Article

Search Tools: